Highbridge Capital Management LLC Adverum Biotechnologies, Inc. Call Options Transaction History

Highbridge Capital Management LLC

1 transactions

Quarter	Operation	Price Per call	calls change	calls Held	SEC Form
Q4 2017 Feb 14, 2018	BUY	$2.85 - $3.95 $1.14 Million - $1.58 Million	400,000	400,000 $1.4 Million

524K

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $681M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

Get notified when there are updates to the investment portfolio of Highbridge Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Highbridge Capital Management LLC with notifications on news.